Shopping Cart 0
Cart Subtotal
AED 0

Global Oncolytic Virus Therapy Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 17910

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 26864

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 35819

Details

Summary

Market Overview

The global Oncolytic Virus Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 23.8% in the forecast period of 2020 to 2025 and will expected to reach USD 9 million by 2025, from USD 4 million in 2019.

The Oncolytic Virus Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Oncolytic Virus Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Oncolytic Virus Therapy market has been segmented into HSV-based Oncolytic Viruses, Adenoviruses-based Oncolytic Viruses, Vaccinia Virus-based Oncolytic Viruses, Vesicular Stomatitis Virus-based Oncolytic Viruses, Newcastle Disease Virus-based Oncolytic Viruses, etc.

By Application, Oncolytic Virus Therapy has been segmented into Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Others, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Oncolytic Virus Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Oncolytic Virus Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oncolytic Virus Therapy market.

The report offers in-depth assessment of the growth and other aspects of the Oncolytic Virus Therapy market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Oncolytic Virus Therapy markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.

Competitive Landscape and Oncolytic Virus Therapy Market Share Analysis

Oncolytic Virus Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oncolytic Virus Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oncolytic Virus Therapy sales, revenue and market share for each player covered in this report.

The major players covered in Oncolytic Virus Therapy are: Amgen, SillaJen Biotherapeutics, Transgene SA, Oncolytics Biotech, PsiOxus Therapeutics, Viralytics, Lokon Pharma, Targovax, Oncolys BioPharma, Sorrento Therapeutics, Genelux Corporation, Cold Genesys, Vyriad, TILT Biotherapeutics, etc. Among other players domestic and global, Oncolytic Virus Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

READ MORE

Table Of Content

Scope

Table of Contents

1 Oncolytic Virus Therapy Market Overview

1.1 Product Overview and Scope of Oncolytic Virus Therapy

1.2 Classification of Oncolytic Virus Therapy by Type

1.2.1 Global Oncolytic Virus Therapy Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Global Oncolytic Virus Therapy Revenue Market Share by Type in 2019

1.2.3 HSV-based Oncolytic Viruses

1.2.4 Adenoviruses-based Oncolytic Viruses

1.2.5 Vaccinia Virus-based Oncolytic Viruses

1.2.6 Vesicular Stomatitis Virus-based Oncolytic Viruses

1.2.7 Newcastle Disease Virus-based Oncolytic Viruses

1.3 Global Oncolytic Virus Therapy Market by Application

1.3.1 Overview: Global Oncolytic Virus Therapy Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Melanoma

1.3.3 Prostate Cancer

1.3.4 Breast Cancer

1.3.5 Ovarian Cancer

1.3.6 Others

1.4 Global Oncolytic Virus Therapy Market by Regions

1.4.1 Global Oncolytic Virus Therapy Market Size by Regions: 2015 VS 2019 VS 2025

1.4.2 Global Market Size of Oncolytic Virus Therapy (2015-2025)

1.4.3 North America (USA, Canada and Mexico) Oncolytic Virus Therapy Status and Prospect (2015-2025)

1.4.4 Europe (Germany, France, UK, Russia and Italy) Oncolytic Virus Therapy Status and Prospect (2015-2025)

1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncolytic Virus Therapy Status and Prospect (2015-2025)

1.4.6 South America (Brazil, Argentina, Colombia) Oncolytic Virus Therapy Status and Prospect (2015-2025)

1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncolytic Virus Therapy Status and Prospect (2015-2025)

2 Company Profiles

2.1 Amgen

2.1.1 Amgen Details

2.1.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Amgen SWOT Analysis

2.1.4 Amgen Product and Services

2.1.5 Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.2 SillaJen Biotherapeutics

2.2.1 SillaJen Biotherapeutics Details

2.2.2 SillaJen Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 SillaJen Biotherapeutics SWOT Analysis

2.2.4 SillaJen Biotherapeutics Product and Services

2.2.5 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.3 Transgene SA

2.3.1 Transgene SA Details

2.3.2 Transgene SA Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Transgene SA SWOT Analysis

2.3.4 Transgene SA Product and Services

2.3.5 Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.4 Oncolytics Biotech

2.4.1 Oncolytics Biotech Details

2.4.2 Oncolytics Biotech Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Oncolytics Biotech SWOT Analysis

2.4.4 Oncolytics Biotech Product and Services

2.4.5 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.5 PsiOxus Therapeutics

2.5.1 PsiOxus Therapeutics Details

2.5.2 PsiOxus Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 PsiOxus Therapeutics SWOT Analysis

2.5.4 PsiOxus Therapeutics Product and Services

2.5.5 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.6 Viralytics

2.6.1 Viralytics Details

2.6.2 Viralytics Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Viralytics SWOT Analysis

2.6.4 Viralytics Product and Services

2.6.5 Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.7 Lokon Pharma

2.7.1 Lokon Pharma Details

2.7.2 Lokon Pharma Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Lokon Pharma SWOT Analysis

2.7.4 Lokon Pharma Product and Services

2.7.5 Lokon Pharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.8 Targovax

2.8.1 Targovax Details

2.8.2 Targovax Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Targovax SWOT Analysis

2.8.4 Targovax Product and Services

2.8.5 Targovax Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.9 Oncolys BioPharma

2.9.1 Oncolys BioPharma Details

2.9.2 Oncolys BioPharma Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Oncolys BioPharma SWOT Analysis

2.9.4 Oncolys BioPharma Product and Services

2.9.5 Oncolys BioPharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.10 Sorrento Therapeutics

2.10.1 Sorrento Therapeutics Details

2.10.2 Sorrento Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Sorrento Therapeutics SWOT Analysis

2.10.4 Sorrento Therapeutics Product and Services

2.10.5 Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.11 Genelux Corporation

2.11.1 Genelux Corporation Details

2.11.2 Genelux Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.11.3 Genelux Corporation SWOT Analysis

2.11.4 Genelux Corporation Product and Services

2.11.5 Genelux Corporation Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.12 Cold Genesys

2.12.1 Cold Genesys Details

2.12.2 Cold Genesys Major Business and Total Revenue (Financial Highlights) Analysis

2.12.3 Cold Genesys SWOT Analysis

2.12.4 Cold Genesys Product and Services

2.12.5 Cold Genesys Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.13 Vyriad

2.13.1 Vyriad Details

2.13.2 Vyriad Major Business and Total Revenue (Financial Highlights) Analysis

2.13.3 Vyriad SWOT Analysis

2.13.4 Vyriad Product and Services

2.13.5 Vyriad Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.14 TILT Biotherapeutics

2.14.1 TILT Biotherapeutics Details

2.14.2 TILT Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis

2.14.3 TILT Biotherapeutics SWOT Analysis

2.14.4 TILT Biotherapeutics Product and Services

2.14.5 TILT Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Oncolytic Virus Therapy Revenue and Share by Players (2015-2020)

3.2 Market Concentration Rate

3.2.1 Top 5 Oncolytic Virus Therapy Players Market Share

3.2.2 Top 10 Oncolytic Virus Therapy Players Market Share

3.3 Market Competition Trend

4 Market Size by Regions

4.1 Global Oncolytic Virus Therapy Revenue and Market Share by Regions

4.2 North America Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

4.3 Europe Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

4.4 Asia-Pacific Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

4.5 South America Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

4.6 Middle East & Africa Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

5 North America Oncolytic Virus Therapy Revenue by Countries

5.1 North America Oncolytic Virus Therapy Revenue by Countries (2015-2020)

5.2 USA Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

5.3 Canada Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

5.4 Mexico Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

6 Europe Oncolytic Virus Therapy Revenue by Countries

6.1 Europe Oncolytic Virus Therapy Revenue by Countries (2015-2020)

6.2 Germany Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

6.3 UK Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

6.4 France Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

6.5 Russia Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

6.6 Italy Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Oncolytic Virus Therapy Revenue by Countries

7.1 Asia-Pacific Oncolytic Virus Therapy Revenue by Countries (2015-2020)

7.2 China Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

7.3 Japan Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

7.4 Korea Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

7.5 India Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

7.6 Southeast Asia Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

8 South America Oncolytic Virus Therapy Revenue by Countries

8.1 South America Oncolytic Virus Therapy Revenue by Countries (2015-2020)

8.2 Brazil Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

8.3 Argentina Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Oncolytic Virus Therapy by Countries

9.1 Middle East & Africa Oncolytic Virus Therapy Revenue by Countries (2015-2020)

9.2 Saudi Arabia Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

9.3 UAE Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

9.4 Egypt Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

9.5 South Africa Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

10.1 Global Oncolytic Virus Therapy Revenue and Market Share by Type (2015-2020)

10.2 Global Oncolytic Virus Therapy Market Forecast by Type (2019-2024)

10.3 HSV-based Oncolytic Viruses Revenue Growth Rate (2015-2025)

10.4 Adenoviruses-based Oncolytic Viruses Revenue Growth Rate (2015-2025)

10.5 Vaccinia Virus-based Oncolytic Viruses Revenue Growth Rate (2015-2025)

10.6 Vesicular Stomatitis Virus-based Oncolytic Viruses Revenue Growth Rate (2015-2025)

10.7 Newcastle Disease Virus-based Oncolytic Viruses Revenue Growth Rate (2015-2025)

11 Global Oncolytic Virus Therapy Market Segment by Application

11.1 Global Oncolytic Virus Therapy Revenue Market Share by Application (2015-2020)

11.2 Oncolytic Virus Therapy Market Forecast by Application (2019-2024)

11.3 Melanoma Revenue Growth (2015-2020)

11.4 Prostate Cancer Revenue Growth (2015-2020)

11.5 Breast Cancer Revenue Growth (2015-2020)

11.6 Ovarian Cancer Revenue Growth (2015-2020)

11.7 Others Revenue Growth (2015-2020)

12 Global Oncolytic Virus Therapy Market Size Forecast (2021-2025)

12.1 Global Oncolytic Virus Therapy Market Size Forecast (2021-2025)

12.2 Global Oncolytic Virus Therapy Market Forecast by Regions (2021-2025)

12.3 North America Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

12.4 Europe Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

12.5 Asia-Pacific Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

12.6 South America Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

12.7 Middle East & Africa Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US


List Of Figure

List of Tables

Table 1. Global Oncolytic Virus Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Oncolytic Virus Therapy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Oncolytic Virus Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global Market Oncolytic Virus Therapy Revenue (Million USD) Comparison by Regions 2015-2025

Table 5. Amgen Corporate Information, Location and Competitors

Table 6. Amgen Oncolytic Virus Therapy Major Business

Table 7. Amgen Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 8. Amgen SWOT Analysis

Table 9. Amgen Oncolytic Virus Therapy Product and Solutions

Table 10. Amgen Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 11. SillaJen Biotherapeutics Corporate Information, Location and Competitors

Table 12. SillaJen Biotherapeutics Oncolytic Virus Therapy Major Business

Table 13. SillaJen Biotherapeutics Oncolytic Virus Therapy Total Revenue (USD Million) (2018-2019)

Table 14. SillaJen Biotherapeutics SWOT Analysis

Table 15. SillaJen Biotherapeutics Oncolytic Virus Therapy Product and Solutions

Table 16. SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 17. Transgene SA Corporate Information, Location and Competitors

Table 18. Transgene SA Oncolytic Virus Therapy Major Business

Table 19. Transgene SA Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 20. Transgene SA SWOT Analysis

Table 21. Transgene SA Oncolytic Virus Therapy Product and Solutions

Table 22. Transgene SA Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 23. Oncolytics Biotech Corporate Information, Location and Competitors

Table 24. Oncolytics Biotech Oncolytic Virus Therapy Major Business

Table 25. Oncolytics Biotech Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 26. Oncolytics Biotech SWOT Analysis

Table 27. Oncolytics Biotech Oncolytic Virus Therapy Product and Solutions

Table 28. Oncolytics Biotech Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 29. PsiOxus Therapeutics Corporate Information, Location and Competitors

Table 30. PsiOxus Therapeutics Oncolytic Virus Therapy Major Business

Table 31. PsiOxus Therapeutics Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 32. PsiOxus Therapeutics SWOT Analysis

Table 33. PsiOxus Therapeutics Oncolytic Virus Therapy Product and Solutions

Table 34. PsiOxus Therapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 35. Viralytics Corporate Information, Location and Competitors

Table 36. Viralytics Oncolytic Virus Therapy Major Business

Table 37. Viralytics Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 38. Viralytics SWOT Analysis

Table 39. Viralytics Oncolytic Virus Therapy Product and Solutions

Table 40. Viralytics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 41. Lokon Pharma Corporate Information, Location and Competitors

Table 42. Lokon Pharma Oncolytic Virus Therapy Major Business

Table 43. Lokon Pharma Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 44. Lokon Pharma SWOT Analysis

Table 45. Lokon Pharma Oncolytic Virus Therapy Product and Solutions

Table 46. Lokon Pharma Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 47. Targovax Corporate Information, Location and Competitors

Table 48. Targovax Oncolytic Virus Therapy Major Business

Table 49. Targovax Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 50. Targovax SWOT Analysis

Table 51. Targovax Oncolytic Virus Therapy Product and Solutions

Table 52. Targovax Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 53. Oncolys BioPharma Corporate Information, Location and Competitors

Table 54. Oncolys BioPharma Oncolytic Virus Therapy Major Business

Table 55. Oncolys BioPharma Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 56. Oncolys BioPharma SWOT Analysis

Table 57. Oncolys BioPharma Oncolytic Virus Therapy Product and Solutions

Table 58. Oncolys BioPharma Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 59. Sorrento Therapeutics Corporate Information, Location and Competitors

Table 60. Sorrento Therapeutics Oncolytic Virus Therapy Major Business

Table 61. Sorrento Therapeutics Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 62. Sorrento Therapeutics SWOT Analysis

Table 63. Sorrento Therapeutics Oncolytic Virus Therapy Product and Solutions

Table 64. Sorrento Therapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 65. Genelux Corporation Corporate Information, Location and Competitors

Table 66. Genelux Corporation Oncolytic Virus Therapy Major Business

Table 67. Genelux Corporation Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 68. Genelux Corporation SWOT Analysis

Table 69. Genelux Corporation Oncolytic Virus Therapy Product and Solutions

Table 70. Genelux Corporation Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 71. Cold Genesys Corporate Information, Location and Competitors

Table 72. Cold Genesys Oncolytic Virus Therapy Major Business

Table 73. Cold Genesys Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 74. Cold Genesys SWOT Analysis

Table 75. Cold Genesys Oncolytic Virus Therapy Product and Solutions

Table 76. Cold Genesys Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 77. Vyriad Corporate Information, Location and Competitors

Table 78. Vyriad Oncolytic Virus Therapy Major Business

Table 79. Vyriad Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 80. Vyriad SWOT Analysis

Table 81. Vyriad Oncolytic Virus Therapy Product and Solutions

Table 82. Vyriad Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 83. TILT Biotherapeutics Corporate Information, Location and Competitors

Table 84. TILT Biotherapeutics Oncolytic Virus Therapy Major Business

Table 85. TILT Biotherapeutics Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 86. TILT Biotherapeutics SWOT Analysis

Table 87. TILT Biotherapeutics Oncolytic Virus Therapy Product and Solutions

Table 88. TILT Biotherapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 89. Global Oncolytic Virus Therapy Revenue (Million USD) by Players (2015-2020)

Table 90. Global Oncolytic Virus Therapy Revenue Share by Players (2015-2020)

Table 91. Global Oncolytic Virus Therapy Revenue (Million USD) by Regions (2015-2020)

Table 92. Global Oncolytic Virus Therapy Revenue Market Share by Regions (2015-2020)

Table 93. North America Oncolytic Virus Therapy Revenue by Countries (2015-2020)

Table 94. North America Oncolytic Virus Therapy Revenue Market Share by Countries (2015-2020)

Table 95. Europe Oncolytic Virus Therapy Revenue (Million USD) by Countries (2015-2020)

Table 96. Asia-Pacific Oncolytic Virus Therapy Revenue (Million USD) by Countries (2015-2020)

Table 97. South America Oncolytic Virus Therapy Revenue by Countries (2015-2020)

Table 98. South America Oncolytic Virus Therapy Revenue Market Share by Countries (2015-2020)

Table 99. Middle East and Africa Oncolytic Virus Therapy Revenue (Million USD) by Countries (2015-2020)

Table 100. Middle East and Africa Oncolytic Virus Therapy Revenue Market Share by Countries (2015-2020)

Table 101. Global Oncolytic Virus Therapy Revenue (Million USD) by Type (2015-2020)

Table 102. Global Oncolytic Virus Therapy Revenue Share by Type (2015-2020)

Table 103. Global Oncolytic Virus Therapy Revenue Forecast by Type (2021-2025)

Table 104. Global Oncolytic Virus Therapy Revenue by Application (2015-2020)

Table 105. Global Oncolytic Virus Therapy Revenue Share by Application (2015-2020)

Table 106. Global Oncolytic Virus Therapy Revenue Forecast by Application (2021-2025)

Table 107. Global Oncolytic Virus Therapy Revenue (Million USD) Forecast by Regions (2021-2025)

List of Figures

Figure 1. Oncolytic Virus Therapy Picture

Figure 2. Global Oncolytic Virus Therapy Revenue Market Share by Type in 2019

Figure 3. HSV-based Oncolytic Viruses Picture

Figure 4. Adenoviruses-based Oncolytic Viruses Picture

Figure 5. Vaccinia Virus-based Oncolytic Viruses Picture

Figure 6. Vesicular Stomatitis Virus-based Oncolytic Viruses Picture

Figure 7. Newcastle Disease Virus-based Oncolytic Viruses Picture

Figure 8. Oncolytic Virus Therapy Revenue Market Share by Application in 2019

Figure 9. Melanoma Picture

Figure 10. Prostate Cancer Picture

Figure 11. Breast Cancer Picture

Figure 12. Ovarian Cancer Picture

Figure 13. Others Picture

Figure 14. Global Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2015-2025)

Figure 15. North America Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2015-2025)

Figure 16. Europe Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2015-2025)

Figure 17. Asia-Pacific Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2015-2025)

Figure 18. South America Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2015-2025)

Figure 19. Middle East and Africa Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2015-2025)

Figure 20. Global Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2015-2025)

Figure 21. Global Oncolytic Virus Therapy Revenue Share by Players in 2019

Figure 22. Global Top 5 Players Oncolytic Virus Therapy Revenue Market Share in 2019

Figure 23. Global Top 10 Players Oncolytic Virus Therapy Revenue Market Share in 2019

Figure 24. Key Players Market Share Trend

Figure 25. Global Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)

Figure 26. Global Oncolytic Virus Therapy Revenue Market Share by Regions (2015-2020)

Figure 27. Global Oncolytic Virus Therapy Revenue Market Share by Regions in 2018

Figure 28. North America Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 29. Europe Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 30. Asia-Pacific Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 31. South America Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 32. Middle East and Africa Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 33. North America Oncolytic Virus Therapy Revenue Market Share by Countries (2015-2020)

Figure 34. North America Oncolytic Virus Therapy Revenue Market Share by Countries in 2019

Figure 35. USA Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 36. Canada Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 37. Mexico Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 38. Europe Oncolytic Virus Therapy Revenue Market Share by Countries (2015-2020)

Figure 39. Europe Oncolytic Virus Therapy Revenue Market Share by Countries in 2019

Figure 40. Germany Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 41. UK Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 42. France Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 43. Russia Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 44. Italy Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 45. Asia-Pacific Oncolytic Virus Therapy Revenue Market Share by Countries (2015-2020)

Figure 46. Asia-Pacific Oncolytic Virus Therapy Revenue Market Share by Countries in 2019

Figure 47. China Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 48. Japan Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 49. Korea Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 50. India Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 51. Southeast Asia Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 52. South America Oncolytic Virus Therapy Revenue Market Share by Countries (2015-2020)

Figure 53. South America Oncolytic Virus Therapy Revenue Market Share by Countries in 2019

Figure 54. Brazil Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 55. Argentina Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 56. Middle East and Africa Oncolytic Virus Therapy Revenue Market Share by Countries (2015-2020)

Figure 57. Middle East and Africa Oncolytic Virus Therapy Revenue Market Share by Countries in 2019

Figure 58. Saudi Arabia Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 59. UAE Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 60. Egypt Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 61. South Africa Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 62. Global Oncolytic Virus Therapy Revenue Share by Type (2015-2020)

Figure 63. Global Oncolytic Virus Therapy Revenue Share by Type in 2019

Figure 64. Global Oncolytic Virus Therapy Market Share Forecast by Type (2021-2025)

Figure 65. Global HSV-based Oncolytic Viruses Revenue Growth Rate (2015-2020)

Figure 66. Global Adenoviruses-based Oncolytic Viruses Revenue Growth Rate (2015-2020)

Figure 67. Global Vaccinia Virus-based Oncolytic Viruses Revenue Growth Rate (2015-2020)

Figure 68. Global Vesicular Stomatitis Virus-based Oncolytic Viruses Revenue Growth Rate (2015-2020)

Figure 69. Global Newcastle Disease Virus-based Oncolytic Viruses Revenue Growth Rate (2015-2020)

Figure 70. Global Oncolytic Virus Therapy Revenue Share by Application (2015-2020)

Figure 71. Global Oncolytic Virus Therapy Revenue Share by Application in 2019

Figure 72. Global Oncolytic Virus Therapy Market Share Forecast by Application (2021-2025)

Figure 73. Global Melanoma Revenue Growth Rate (2015-2020)

Figure 74. Global Prostate Cancer Revenue Growth Rate (2015-2020)

Figure 75. Global Breast Cancer Revenue Growth Rate (2015-2020)

Figure 76. Global Ovarian Cancer Revenue Growth Rate (2015-2020)

Figure 77. Global Others Revenue Growth Rate (2015-2020)

Figure 78. Global Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)

Figure 79. Global Oncolytic Virus Therapy Revenue (Million USD) Forecast by Regions (2021-2025)

Figure 80. Global Oncolytic Virus Therapy Revenue Market Share Forecast by Regions (2021-2025)

Figure 81. North America Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

Figure 82. Europe Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

Figure 83. Asia-Pacific Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

Figure 84. South America Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

Figure 85. Middle East and Africa Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

Figure 86. Sales Channel: Direct Channel vs Indirect Channel

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Summary

Market Overview

The global Oncolytic Virus Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 23.8% in the forecast period of 2020 to 2025 and will expected to reach USD 9 million by 2025, from USD 4 million in 2019.

The Oncolytic Virus Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Oncolytic Virus Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Oncolytic Virus Therapy market has been segmented into HSV-based Oncolytic Viruses, Adenoviruses-based Oncolytic Viruses, Vaccinia Virus-based Oncolytic Viruses, Vesicular Stomatitis Virus-based Oncolytic Viruses, Newcastle Disease Virus-based Oncolytic Viruses, etc.

By Application, Oncolytic Virus Therapy has been segmented into Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Others, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Oncolytic Virus Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Oncolytic Virus Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oncolytic Virus Therapy market.

The report offers in-depth assessment of the growth and other aspects of the Oncolytic Virus Therapy market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Oncolytic Virus Therapy markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.

Competitive Landscape and Oncolytic Virus Therapy Market Share Analysis

Oncolytic Virus Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oncolytic Virus Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oncolytic Virus Therapy sales, revenue and market share for each player covered in this report.

The major players covered in Oncolytic Virus Therapy are: Amgen, SillaJen Biotherapeutics, Transgene SA, Oncolytics Biotech, PsiOxus Therapeutics, Viralytics, Lokon Pharma, Targovax, Oncolys BioPharma, Sorrento Therapeutics, Genelux Corporation, Cold Genesys, Vyriad, TILT Biotherapeutics, etc. Among other players domestic and global, Oncolytic Virus Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

READ MORE

Scope

Table of Contents

1 Oncolytic Virus Therapy Market Overview

1.1 Product Overview and Scope of Oncolytic Virus Therapy

1.2 Classification of Oncolytic Virus Therapy by Type

1.2.1 Global Oncolytic Virus Therapy Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Global Oncolytic Virus Therapy Revenue Market Share by Type in 2019

1.2.3 HSV-based Oncolytic Viruses

1.2.4 Adenoviruses-based Oncolytic Viruses

1.2.5 Vaccinia Virus-based Oncolytic Viruses

1.2.6 Vesicular Stomatitis Virus-based Oncolytic Viruses

1.2.7 Newcastle Disease Virus-based Oncolytic Viruses

1.3 Global Oncolytic Virus Therapy Market by Application

1.3.1 Overview: Global Oncolytic Virus Therapy Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Melanoma

1.3.3 Prostate Cancer

1.3.4 Breast Cancer

1.3.5 Ovarian Cancer

1.3.6 Others

1.4 Global Oncolytic Virus Therapy Market by Regions

1.4.1 Global Oncolytic Virus Therapy Market Size by Regions: 2015 VS 2019 VS 2025

1.4.2 Global Market Size of Oncolytic Virus Therapy (2015-2025)

1.4.3 North America (USA, Canada and Mexico) Oncolytic Virus Therapy Status and Prospect (2015-2025)

1.4.4 Europe (Germany, France, UK, Russia and Italy) Oncolytic Virus Therapy Status and Prospect (2015-2025)

1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncolytic Virus Therapy Status and Prospect (2015-2025)

1.4.6 South America (Brazil, Argentina, Colombia) Oncolytic Virus Therapy Status and Prospect (2015-2025)

1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncolytic Virus Therapy Status and Prospect (2015-2025)

2 Company Profiles

2.1 Amgen

2.1.1 Amgen Details

2.1.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Amgen SWOT Analysis

2.1.4 Amgen Product and Services

2.1.5 Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.2 SillaJen Biotherapeutics

2.2.1 SillaJen Biotherapeutics Details

2.2.2 SillaJen Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 SillaJen Biotherapeutics SWOT Analysis

2.2.4 SillaJen Biotherapeutics Product and Services

2.2.5 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.3 Transgene SA

2.3.1 Transgene SA Details

2.3.2 Transgene SA Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Transgene SA SWOT Analysis

2.3.4 Transgene SA Product and Services

2.3.5 Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.4 Oncolytics Biotech

2.4.1 Oncolytics Biotech Details

2.4.2 Oncolytics Biotech Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Oncolytics Biotech SWOT Analysis

2.4.4 Oncolytics Biotech Product and Services

2.4.5 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.5 PsiOxus Therapeutics

2.5.1 PsiOxus Therapeutics Details

2.5.2 PsiOxus Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 PsiOxus Therapeutics SWOT Analysis

2.5.4 PsiOxus Therapeutics Product and Services

2.5.5 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.6 Viralytics

2.6.1 Viralytics Details

2.6.2 Viralytics Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Viralytics SWOT Analysis

2.6.4 Viralytics Product and Services

2.6.5 Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.7 Lokon Pharma

2.7.1 Lokon Pharma Details

2.7.2 Lokon Pharma Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Lokon Pharma SWOT Analysis

2.7.4 Lokon Pharma Product and Services

2.7.5 Lokon Pharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.8 Targovax

2.8.1 Targovax Details

2.8.2 Targovax Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Targovax SWOT Analysis

2.8.4 Targovax Product and Services

2.8.5 Targovax Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.9 Oncolys BioPharma

2.9.1 Oncolys BioPharma Details

2.9.2 Oncolys BioPharma Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Oncolys BioPharma SWOT Analysis

2.9.4 Oncolys BioPharma Product and Services

2.9.5 Oncolys BioPharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.10 Sorrento Therapeutics

2.10.1 Sorrento Therapeutics Details

2.10.2 Sorrento Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Sorrento Therapeutics SWOT Analysis

2.10.4 Sorrento Therapeutics Product and Services

2.10.5 Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.11 Genelux Corporation

2.11.1 Genelux Corporation Details

2.11.2 Genelux Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.11.3 Genelux Corporation SWOT Analysis

2.11.4 Genelux Corporation Product and Services

2.11.5 Genelux Corporation Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.12 Cold Genesys

2.12.1 Cold Genesys Details

2.12.2 Cold Genesys Major Business and Total Revenue (Financial Highlights) Analysis

2.12.3 Cold Genesys SWOT Analysis

2.12.4 Cold Genesys Product and Services

2.12.5 Cold Genesys Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.13 Vyriad

2.13.1 Vyriad Details

2.13.2 Vyriad Major Business and Total Revenue (Financial Highlights) Analysis

2.13.3 Vyriad SWOT Analysis

2.13.4 Vyriad Product and Services

2.13.5 Vyriad Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.14 TILT Biotherapeutics

2.14.1 TILT Biotherapeutics Details

2.14.2 TILT Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis

2.14.3 TILT Biotherapeutics SWOT Analysis

2.14.4 TILT Biotherapeutics Product and Services

2.14.5 TILT Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Oncolytic Virus Therapy Revenue and Share by Players (2015-2020)

3.2 Market Concentration Rate

3.2.1 Top 5 Oncolytic Virus Therapy Players Market Share

3.2.2 Top 10 Oncolytic Virus Therapy Players Market Share

3.3 Market Competition Trend

4 Market Size by Regions

4.1 Global Oncolytic Virus Therapy Revenue and Market Share by Regions

4.2 North America Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

4.3 Europe Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

4.4 Asia-Pacific Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

4.5 South America Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

4.6 Middle East & Africa Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

5 North America Oncolytic Virus Therapy Revenue by Countries

5.1 North America Oncolytic Virus Therapy Revenue by Countries (2015-2020)

5.2 USA Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

5.3 Canada Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

5.4 Mexico Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

6 Europe Oncolytic Virus Therapy Revenue by Countries

6.1 Europe Oncolytic Virus Therapy Revenue by Countries (2015-2020)

6.2 Germany Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

6.3 UK Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

6.4 France Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

6.5 Russia Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

6.6 Italy Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Oncolytic Virus Therapy Revenue by Countries

7.1 Asia-Pacific Oncolytic Virus Therapy Revenue by Countries (2015-2020)

7.2 China Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

7.3 Japan Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

7.4 Korea Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

7.5 India Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

7.6 Southeast Asia Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

8 South America Oncolytic Virus Therapy Revenue by Countries

8.1 South America Oncolytic Virus Therapy Revenue by Countries (2015-2020)

8.2 Brazil Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

8.3 Argentina Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Oncolytic Virus Therapy by Countries

9.1 Middle East & Africa Oncolytic Virus Therapy Revenue by Countries (2015-2020)

9.2 Saudi Arabia Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

9.3 UAE Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

9.4 Egypt Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

9.5 South Africa Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

10.1 Global Oncolytic Virus Therapy Revenue and Market Share by Type (2015-2020)

10.2 Global Oncolytic Virus Therapy Market Forecast by Type (2019-2024)

10.3 HSV-based Oncolytic Viruses Revenue Growth Rate (2015-2025)

10.4 Adenoviruses-based Oncolytic Viruses Revenue Growth Rate (2015-2025)

10.5 Vaccinia Virus-based Oncolytic Viruses Revenue Growth Rate (2015-2025)

10.6 Vesicular Stomatitis Virus-based Oncolytic Viruses Revenue Growth Rate (2015-2025)

10.7 Newcastle Disease Virus-based Oncolytic Viruses Revenue Growth Rate (2015-2025)

11 Global Oncolytic Virus Therapy Market Segment by Application

11.1 Global Oncolytic Virus Therapy Revenue Market Share by Application (2015-2020)

11.2 Oncolytic Virus Therapy Market Forecast by Application (2019-2024)

11.3 Melanoma Revenue Growth (2015-2020)

11.4 Prostate Cancer Revenue Growth (2015-2020)

11.5 Breast Cancer Revenue Growth (2015-2020)

11.6 Ovarian Cancer Revenue Growth (2015-2020)

11.7 Others Revenue Growth (2015-2020)

12 Global Oncolytic Virus Therapy Market Size Forecast (2021-2025)

12.1 Global Oncolytic Virus Therapy Market Size Forecast (2021-2025)

12.2 Global Oncolytic Virus Therapy Market Forecast by Regions (2021-2025)

12.3 North America Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

12.4 Europe Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

12.5 Asia-Pacific Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

12.6 South America Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

12.7 Middle East & Africa Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US


List Of Figure

List of Tables

Table 1. Global Oncolytic Virus Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Oncolytic Virus Therapy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Oncolytic Virus Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global Market Oncolytic Virus Therapy Revenue (Million USD) Comparison by Regions 2015-2025

Table 5. Amgen Corporate Information, Location and Competitors

Table 6. Amgen Oncolytic Virus Therapy Major Business

Table 7. Amgen Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 8. Amgen SWOT Analysis

Table 9. Amgen Oncolytic Virus Therapy Product and Solutions

Table 10. Amgen Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 11. SillaJen Biotherapeutics Corporate Information, Location and Competitors

Table 12. SillaJen Biotherapeutics Oncolytic Virus Therapy Major Business

Table 13. SillaJen Biotherapeutics Oncolytic Virus Therapy Total Revenue (USD Million) (2018-2019)

Table 14. SillaJen Biotherapeutics SWOT Analysis

Table 15. SillaJen Biotherapeutics Oncolytic Virus Therapy Product and Solutions

Table 16. SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 17. Transgene SA Corporate Information, Location and Competitors

Table 18. Transgene SA Oncolytic Virus Therapy Major Business

Table 19. Transgene SA Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 20. Transgene SA SWOT Analysis

Table 21. Transgene SA Oncolytic Virus Therapy Product and Solutions

Table 22. Transgene SA Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 23. Oncolytics Biotech Corporate Information, Location and Competitors

Table 24. Oncolytics Biotech Oncolytic Virus Therapy Major Business

Table 25. Oncolytics Biotech Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 26. Oncolytics Biotech SWOT Analysis

Table 27. Oncolytics Biotech Oncolytic Virus Therapy Product and Solutions

Table 28. Oncolytics Biotech Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 29. PsiOxus Therapeutics Corporate Information, Location and Competitors

Table 30. PsiOxus Therapeutics Oncolytic Virus Therapy Major Business

Table 31. PsiOxus Therapeutics Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 32. PsiOxus Therapeutics SWOT Analysis

Table 33. PsiOxus Therapeutics Oncolytic Virus Therapy Product and Solutions

Table 34. PsiOxus Therapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 35. Viralytics Corporate Information, Location and Competitors

Table 36. Viralytics Oncolytic Virus Therapy Major Business

Table 37. Viralytics Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 38. Viralytics SWOT Analysis

Table 39. Viralytics Oncolytic Virus Therapy Product and Solutions

Table 40. Viralytics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 41. Lokon Pharma Corporate Information, Location and Competitors

Table 42. Lokon Pharma Oncolytic Virus Therapy Major Business

Table 43. Lokon Pharma Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 44. Lokon Pharma SWOT Analysis

Table 45. Lokon Pharma Oncolytic Virus Therapy Product and Solutions

Table 46. Lokon Pharma Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 47. Targovax Corporate Information, Location and Competitors

Table 48. Targovax Oncolytic Virus Therapy Major Business

Table 49. Targovax Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 50. Targovax SWOT Analysis

Table 51. Targovax Oncolytic Virus Therapy Product and Solutions

Table 52. Targovax Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 53. Oncolys BioPharma Corporate Information, Location and Competitors

Table 54. Oncolys BioPharma Oncolytic Virus Therapy Major Business

Table 55. Oncolys BioPharma Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 56. Oncolys BioPharma SWOT Analysis

Table 57. Oncolys BioPharma Oncolytic Virus Therapy Product and Solutions

Table 58. Oncolys BioPharma Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 59. Sorrento Therapeutics Corporate Information, Location and Competitors

Table 60. Sorrento Therapeutics Oncolytic Virus Therapy Major Business

Table 61. Sorrento Therapeutics Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 62. Sorrento Therapeutics SWOT Analysis

Table 63. Sorrento Therapeutics Oncolytic Virus Therapy Product and Solutions

Table 64. Sorrento Therapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 65. Genelux Corporation Corporate Information, Location and Competitors

Table 66. Genelux Corporation Oncolytic Virus Therapy Major Business

Table 67. Genelux Corporation Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 68. Genelux Corporation SWOT Analysis

Table 69. Genelux Corporation Oncolytic Virus Therapy Product and Solutions

Table 70. Genelux Corporation Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 71. Cold Genesys Corporate Information, Location and Competitors

Table 72. Cold Genesys Oncolytic Virus Therapy Major Business

Table 73. Cold Genesys Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 74. Cold Genesys SWOT Analysis

Table 75. Cold Genesys Oncolytic Virus Therapy Product and Solutions

Table 76. Cold Genesys Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 77. Vyriad Corporate Information, Location and Competitors

Table 78. Vyriad Oncolytic Virus Therapy Major Business

Table 79. Vyriad Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 80. Vyriad SWOT Analysis

Table 81. Vyriad Oncolytic Virus Therapy Product and Solutions

Table 82. Vyriad Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 83. TILT Biotherapeutics Corporate Information, Location and Competitors

Table 84. TILT Biotherapeutics Oncolytic Virus Therapy Major Business

Table 85. TILT Biotherapeutics Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 86. TILT Biotherapeutics SWOT Analysis

Table 87. TILT Biotherapeutics Oncolytic Virus Therapy Product and Solutions

Table 88. TILT Biotherapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 89. Global Oncolytic Virus Therapy Revenue (Million USD) by Players (2015-2020)

Table 90. Global Oncolytic Virus Therapy Revenue Share by Players (2015-2020)

Table 91. Global Oncolytic Virus Therapy Revenue (Million USD) by Regions (2015-2020)

Table 92. Global Oncolytic Virus Therapy Revenue Market Share by Regions (2015-2020)

Table 93. North America Oncolytic Virus Therapy Revenue by Countries (2015-2020)

Table 94. North America Oncolytic Virus Therapy Revenue Market Share by Countries (2015-2020)

Table 95. Europe Oncolytic Virus Therapy Revenue (Million USD) by Countries (2015-2020)

Table 96. Asia-Pacific Oncolytic Virus Therapy Revenue (Million USD) by Countries (2015-2020)

Table 97. South America Oncolytic Virus Therapy Revenue by Countries (2015-2020)

Table 98. South America Oncolytic Virus Therapy Revenue Market Share by Countries (2015-2020)

Table 99. Middle East and Africa Oncolytic Virus Therapy Revenue (Million USD) by Countries (2015-2020)

Table 100. Middle East and Africa Oncolytic Virus Therapy Revenue Market Share by Countries (2015-2020)

Table 101. Global Oncolytic Virus Therapy Revenue (Million USD) by Type (2015-2020)

Table 102. Global Oncolytic Virus Therapy Revenue Share by Type (2015-2020)

Table 103. Global Oncolytic Virus Therapy Revenue Forecast by Type (2021-2025)

Table 104. Global Oncolytic Virus Therapy Revenue by Application (2015-2020)

Table 105. Global Oncolytic Virus Therapy Revenue Share by Application (2015-2020)

Table 106. Global Oncolytic Virus Therapy Revenue Forecast by Application (2021-2025)

Table 107. Global Oncolytic Virus Therapy Revenue (Million USD) Forecast by Regions (2021-2025)

List of Figures

Figure 1. Oncolytic Virus Therapy Picture

Figure 2. Global Oncolytic Virus Therapy Revenue Market Share by Type in 2019

Figure 3. HSV-based Oncolytic Viruses Picture

Figure 4. Adenoviruses-based Oncolytic Viruses Picture

Figure 5. Vaccinia Virus-based Oncolytic Viruses Picture

Figure 6. Vesicular Stomatitis Virus-based Oncolytic Viruses Picture

Figure 7. Newcastle Disease Virus-based Oncolytic Viruses Picture

Figure 8. Oncolytic Virus Therapy Revenue Market Share by Application in 2019

Figure 9. Melanoma Picture

Figure 10. Prostate Cancer Picture

Figure 11. Breast Cancer Picture

Figure 12. Ovarian Cancer Picture

Figure 13. Others Picture

Figure 14. Global Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2015-2025)

Figure 15. North America Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2015-2025)

Figure 16. Europe Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2015-2025)

Figure 17. Asia-Pacific Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2015-2025)

Figure 18. South America Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2015-2025)

Figure 19. Middle East and Africa Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2015-2025)

Figure 20. Global Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2015-2025)

Figure 21. Global Oncolytic Virus Therapy Revenue Share by Players in 2019

Figure 22. Global Top 5 Players Oncolytic Virus Therapy Revenue Market Share in 2019

Figure 23. Global Top 10 Players Oncolytic Virus Therapy Revenue Market Share in 2019

Figure 24. Key Players Market Share Trend

Figure 25. Global Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)

Figure 26. Global Oncolytic Virus Therapy Revenue Market Share by Regions (2015-2020)

Figure 27. Global Oncolytic Virus Therapy Revenue Market Share by Regions in 2018

Figure 28. North America Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 29. Europe Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 30. Asia-Pacific Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 31. South America Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 32. Middle East and Africa Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 33. North America Oncolytic Virus Therapy Revenue Market Share by Countries (2015-2020)

Figure 34. North America Oncolytic Virus Therapy Revenue Market Share by Countries in 2019

Figure 35. USA Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 36. Canada Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 37. Mexico Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 38. Europe Oncolytic Virus Therapy Revenue Market Share by Countries (2015-2020)

Figure 39. Europe Oncolytic Virus Therapy Revenue Market Share by Countries in 2019

Figure 40. Germany Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 41. UK Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 42. France Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 43. Russia Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 44. Italy Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 45. Asia-Pacific Oncolytic Virus Therapy Revenue Market Share by Countries (2015-2020)

Figure 46. Asia-Pacific Oncolytic Virus Therapy Revenue Market Share by Countries in 2019

Figure 47. China Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 48. Japan Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 49. Korea Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 50. India Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 51. Southeast Asia Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 52. South America Oncolytic Virus Therapy Revenue Market Share by Countries (2015-2020)

Figure 53. South America Oncolytic Virus Therapy Revenue Market Share by Countries in 2019

Figure 54. Brazil Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 55. Argentina Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 56. Middle East and Africa Oncolytic Virus Therapy Revenue Market Share by Countries (2015-2020)

Figure 57. Middle East and Africa Oncolytic Virus Therapy Revenue Market Share by Countries in 2019

Figure 58. Saudi Arabia Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 59. UAE Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 60. Egypt Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 61. South Africa Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

Figure 62. Global Oncolytic Virus Therapy Revenue Share by Type (2015-2020)

Figure 63. Global Oncolytic Virus Therapy Revenue Share by Type in 2019

Figure 64. Global Oncolytic Virus Therapy Market Share Forecast by Type (2021-2025)

Figure 65. Global HSV-based Oncolytic Viruses Revenue Growth Rate (2015-2020)

Figure 66. Global Adenoviruses-based Oncolytic Viruses Revenue Growth Rate (2015-2020)

Figure 67. Global Vaccinia Virus-based Oncolytic Viruses Revenue Growth Rate (2015-2020)

Figure 68. Global Vesicular Stomatitis Virus-based Oncolytic Viruses Revenue Growth Rate (2015-2020)

Figure 69. Global Newcastle Disease Virus-based Oncolytic Viruses Revenue Growth Rate (2015-2020)

Figure 70. Global Oncolytic Virus Therapy Revenue Share by Application (2015-2020)

Figure 71. Global Oncolytic Virus Therapy Revenue Share by Application in 2019

Figure 72. Global Oncolytic Virus Therapy Market Share Forecast by Application (2021-2025)

Figure 73. Global Melanoma Revenue Growth Rate (2015-2020)

Figure 74. Global Prostate Cancer Revenue Growth Rate (2015-2020)

Figure 75. Global Breast Cancer Revenue Growth Rate (2015-2020)

Figure 76. Global Ovarian Cancer Revenue Growth Rate (2015-2020)

Figure 77. Global Others Revenue Growth Rate (2015-2020)

Figure 78. Global Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)

Figure 79. Global Oncolytic Virus Therapy Revenue (Million USD) Forecast by Regions (2021-2025)

Figure 80. Global Oncolytic Virus Therapy Revenue Market Share Forecast by Regions (2021-2025)

Figure 81. North America Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

Figure 82. Europe Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

Figure 83. Asia-Pacific Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

Figure 84. South America Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

Figure 85. Middle East and Africa Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

Figure 86. Sales Channel: Direct Channel vs Indirect Channel

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS